Dr Geoffrey Coxon
Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
Dr Geoff Coxon is a lecturer in Medicinal Chemistry. After receiving his PhD from the University of Newcastle upon Tyne, and a short term industry, he moved SIPBS where he set up his research group in the discovery and development of new agents to treat tuberculosis. He is the co-founder and Deputy Leader of TB Drug Discovery UK (www.tbd-uk.org.uk). In this role he works with fellow scientists and clinicians, UK government policy makers and advocates with the goal of strengthening scientific research across all areas of TB drug development as a key part of the UK response in the global eradiation of the disease.
The links here take you to the TBD-UK profile page of Dr Geoff Coxon and the TBD-UK website home page
Prize And Awards
- Teaching Excellence Award
- Recipient
- 2020
- Appointed deputy leader and director of medicinal chemistry of TBD-UK
- Recipient
- 2009
Publications
- Resistance to thiacetazone derivatives active against Mycobacterium abscessus involves mutations in the MmpL5 transcriptional repressor MAB_4384
- Halloum Iman, Viljoen Albertus, Khanna Varun, Craig Derek, Bouchier Christiane, Brosch Roland, Coxon Geoffrey, Kremer Laurent
- , pp. e02509-16:1-14 (2017)
- https://doi.org/10.1128/AAC.02509-16
- Characterisation of triterpenes and new phenolic lipids in Cameroonian propolis
- Kardar M N, Zhang T, Coxon G D, Watson D G, Fearnley J, Seidel V
- Phytochemistry Vol 106, pp. 156-163 (2014)
- https://doi.org/10.1016/j.phytochem.2014.07.016
- Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues
- Coxon Geoffrey, Craig Derek, Corrales Rosa Milagros, Vialla Emilie, Gannoun-Zaki Laila, Kremer Laurent
- PLOS One Vol 8, pp. 1-13 (2013)
- https://doi.org/10.1371/journal.pone.0053162
- Strategies and challenges involved in the discovery of new chemical entities during early-stage tuberculosis drug discovery
- Coxon Geoffrey, Cooper Christopher B, Gillespie Stephen H, McHugh Timothy D
- Journal of Infectious Diseases (2012)
- https://doi.org/10.1093/infdis/jis191
- Synthesis of cis,cis-diunsaturated α-meromycolic acid by a palladium-catalysed alkyl–alkyl Negishi reaction
- Berretta Giacomo, Coxon Geoffrey
- Tetrahedron Letters Vol 53, pp. 214-216 (2012)
- https://doi.org/10.1016/j.tetlet.2011.11.021
- Strategies and challenges involved in the discovry of new chemical entities during early-stage tuberculosis drug discovery
- Coxon Geoffrey
- Tuberculosis: Local and global (2012)
Professional Activities
- Gordon Research conference on TB Drug Development
- Keynote/plenary speaker
- 8/2009
- International Symposium on Tuberculosis , India
- Keynote/plenary speaker
- 1/2008
Projects
- DTP 2224 University of Strathclyde | Cairns, Michael
- Coxon, Geoffrey (Principal Investigator) Perrie, Yvonne (Co-investigator) Cairns, Michael (Research Co-investigator)
- 01-Jan-2023 - 01-Jan-2027
- DTP 2224 University of Strathclyde | Evdokimou, Maria
- Perrie, Yvonne (Principal Investigator) Coxon, Geoffrey (Co-investigator) Evdokimou, Maria (Research Co-investigator)
- 01-Jan-2023 - 01-Jan-2027
- ICDDC - Interacellular Drug Delivery Centre
- Perrie, Yvonne (Principal Investigator) Coxon, Geoffrey (Co-investigator)
- 01-Jan-2023 - 31-Jan-2026
- Pharmacy Elementals
- Coxon, Geoffrey (Principal Investigator)
- 21-Jan-2022 - 31-Jan-2023
- TB Drug Development-UK (TBD-UK)
- Coxon, Geoffrey (Principal Investigator)
- 20-Jan-2009 - 30-Jan-2012
- Thiolactomycin and related inhibitors targeting fatty acid elongase enzymes in Mycobacterium tuberculosis
- MacKay, Simon (Principal Investigator) Coxon, Geoffrey (Co-investigator) Johnston, Blair (Co-investigator)
- 01-Jan-2005 - 30-Jan-2008
Contact
Dr
Geoffrey
Coxon
Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: geoff.coxon@strath.ac.uk
Tel: 548 5754